Formulation
    1.
    发明授权
    Formulation 有权
    公式

    公开(公告)号:US07456160B2

    公开(公告)日:2008-11-25

    申请号:US10872784

    申请日:2004-06-22

    IPC分类号: A61K31/56

    摘要: The invention relates to a novel sustained release pharmaceutical formulation adapted for administration by injection containing the compound 7α-[9-(4,4,5,5,5-pentafluoropentylsulphinyl)nonyl]oestra-1,3,5(10)-triene-3,17β-diol, more particularly to a formulation adapted for administration by injection containing the compound 7α-[9-(4,4,5,5,5-pentafluoropentylsulphinyl)nonyl]oestra-1,3,5(10)-triene-3,17β-diol in solution in a ricinoleate vehicle which additionally comprises at least one alcohol and a non-aqueous ester solvent which is miscible in the ricinoleate vehicle.

    摘要翻译: 本发明涉及适于通过注射给药的新型缓释药物制剂,其含有化合物7α-[9-(4,4,5,5,5-五氟戊基亚磺酰基)壬基]雌甾-1,3,5(10) - 三烯 -3bβ-二醇,更具体地说,涉及一种适于通过注射给药的制剂,其中含有化合物7α-[9-(4,4,5,5,5-五氟戊基亚磺酰基)壬基]雌甾-1,3,5(10) 三烯-3,17b-二醇在蓖麻油酸酯载体中的溶液中,其另外包含至少一种醇和在蓖麻酸酯载体中可混溶的非水酯溶剂。

    Formulation
    2.
    发明授权
    Formulation 有权
    公式

    公开(公告)号:US06774122B2

    公开(公告)日:2004-08-10

    申请号:US09756291

    申请日:2001-01-09

    IPC分类号: A61K3156

    摘要: The invention relates to a novel sustained release pharmaceutical formulation adapted for administration by injection containing the compound 7&agr;-[9-(4,4,5,5,5-pentafluoropentylsulphinyl)nonyl]oestra-1,3,5(10)-triene-3,17&bgr;-diol, more particularly to a formulation adapted for administration by injection containing the compound 7&agr;-[9-(4,4,5,5,5-pentafluoropentylsulphinyl)nonyl]oestra-1,3,5(10)-triene-3,17&bgr;-diol in solution in a ricinoleate vehicle which additionally comprises at least one alcohol and a non-aqueous ester solvent which is miscible in the ricinoleate vehicle.

    摘要翻译: 本发明涉及适于通过注射给药的新型缓释药物制剂,其含有化合物7α-[9-(4,4,5,5,5-五氟戊基亚磺酰基)壬基]雌甾-1,3,5(10) - 三烯 -3bβ-二醇,更具体地说,涉及一种适于通过注射给药的制剂,其中含有化合物7α-[9-(4,4,5,5,5-五氟戊基亚磺酰基)壬基]雌甾-1,3,5(10) 三烯-3,17b-二醇在蓖麻油酸酯载体中的溶液中,其另外包含至少一种醇和在蓖麻酸酯载体中可混溶的非水酯溶剂。

    Formulation
    3.
    发明授权
    Formulation 有权
    公式

    公开(公告)号:US08466139B2

    公开(公告)日:2013-06-18

    申请号:US13602667

    申请日:2012-09-04

    IPC分类号: A61K31/56

    摘要: The invention relates to a novel sustained release pharmaceutical formulation adapted for administration by injection containing the compound 7α-[9-(4,4,5,5,5-pentafluoropentylsulphinyl)nonyl]oestra-1,3,5(10)-triene-3,17β-diol, more particularly to a formulation adapted for administration by injection containing the compound 7α-[9-(4,4,5,5,5-pentafluoropentylsulphinyl)nonyl]oestra-1,3,5(10)-triene-3,17β-diol in solution in a ricinoleate vehicle which additionally comprises at least one alcohol and a non-aqueous ester solvent which is miscible in the ricinoleate vehicle.

    摘要翻译: 本发明涉及适于通过注射给药的新型缓释药物制剂,其含有化合物7α-[9-(4,4,5,5,5-五氟戊基亚磺酰基)壬基]雌甾-1,3,5(10) - 三烯 -3bβ-二醇,更具体地说,涉及一种适于通过注射给药的制剂,其中含有化合物7α-[9-(4,4,5,5,5-五氟戊基亚磺酰基)壬基]雌甾-1,3,5(10) 三烯-3,17b-二醇在蓖麻油酸酯载体中的溶液中,其另外包含至少一种醇和在蓖麻酸酯载体中可混溶的非水酯溶剂。

    Formulation
    4.
    发明授权
    Formulation 有权
    公式

    公开(公告)号:US08329680B2

    公开(公告)日:2012-12-11

    申请号:US12285887

    申请日:2008-10-15

    IPC分类号: A61K31/56

    摘要: The invention relates to a novel sustained release pharmaceutical formulation adapted for administration by injection containing the compound 7α-[9-(4,4,5,5,5-pentafluoropentylsulphinyl)nonyl]oestra-1,3,5(10)-triene-3,17β-diol, more particularly to a formulation adapted for administration by injection containing the compound 7α-[9-(4,4,5,5,5-pentafluoropentylsulphinyl)nonyl]oestra-1,3,5(10)-triene-3,17β-diol in solution in a ricinoleate vehicle which additionally comprises at least one alcohol and a non-aqueous ester solvent which is miscible in the ricinoleate vehicle.

    摘要翻译: 本发明涉及一种适于通过注射给药的新型缓释药物制剂,其含有化合物7α-[9-(4,4,5,5,5-五氟戊基亚磺酰基)壬基]雌甾-1,3,5(10) - 三烯 更具体地说,涉及一种适于通过注射给药的制剂,其中含有化合物7α-[9-(4,4,5,5,5-五氟戊基亚磺酰基)壬基]雌甾-1,3,5(10 ) - 三烯-3,17&bgr二醇在蓖麻油酸酯载体中的溶液中,其另外包含至少一种醇和在蓖麻酸酯载体中可混溶的非水性酯溶剂。